Abstract
Coronary spasm plays an important role in the pathogenesis of ischemic heart disease, including angina pectoris, acute myocardial infarction (AMI), silent myocardial ischemia, and sudden death. The prevalence of coronary spasm is higher among East Asians probably due to genetic as well as environmental factors. ALDH2 eliminates toxic aldehydes including 4-hydroxy-2-nonenal (4-HNE) derived from lipid peroxidation and acrolein in tobacco smoking as well as ethanol-derived acetaldehyde and thereby protects tissues and cells from oxidative damage. Deficient variant ALDH2*2 genotype is prevalent among East Asians and is a significant risk factor for both coronary spasm and AMI through accumulation of toxic aldehydes, thereby contributing to oxidative stress, endothelial damage, vasoconstriction, and thrombosis. Toxic aldehydes are thus identified as risk factors to be targeted for the treatment of coronary spasm and AMI.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, De Mets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW (2013) ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol 61:485–510
Beltrame JF, Crea F, Kaski JC, Ogawa H, Ong P, Sechtem U, Shimokawa H, Bairey Merz CN, Coronary Vasomotion Disorders International Study Group (COVADIS) (2017) International standardization of diagnostic criteria for vasospastic angina. Eur Heart J 38:2565–2568
Bentzon JF, Otsuka F, Virmani R, Falk E (2014) Mechanisms of plaque formation and rupture. Circ Res 114:1852–1866
Beretta M, Gorren AC, Wenzl MV, Weis R, Russwurm M, Koesling D, Schmidt K, Mayer B (2010) Characterization of the east Asian variant of aldehyde dehydrogenase-2: bioactivation of nitroglycerin and effects of Alda-1. J Biol Chem 285:943–952
Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D (2008) Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321:1493–1495
Chen CH, Ferreira JC, Gross ER, Mochly-Rosen D (2014) Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol Rev 94:1–34
Choi BG, Park SH, Rha SW, Ahn J, Choi SY, Byun JK, Li H, Mashaly A, Shim MS, Kang JH, Kim W, Choi JY, Park EJ, Lee S, Na JO, Choi CU, Lim HE, Kim EJ, Park CG, Seo HS, Oh DJ (2017) Three-year follow-up of patients with acetylcholine-induced coronary artery spasm combined with insignificant coronary stenosis. Int J Cardiol 238:66–71
Contractor H, Støttrup NB, Cunnington C, Manlhiot C, Diesch J, Ormerod JO, Jensen R, Bøtker HE, Redington A, Schmidt MR, Ashrafian H, Kharbanda RK (2013) Aldehyde dehydrogenase-2 inhibition blocks remote preconditioning in experimentaland human models. Basic Res Cardiol 108(3):343
Crabb DW, Edenberg HJ, Bosron WF, Li TK (1989) Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant. J Clin Invest 83:314–316
Daiber A, Münzel T (2015) Organic nitrate therapy, nitrate tolerance, and nitrate- induced endothelial dysfunction: emphasis on redox biology and oxidative stress. Antioxid Redox Signal 23(11):899–942
Fournier S, Taffé P, Radovanovic D, Von Elm E, Morawiec B, Stauffer JC, Erne P, Beggah A, Monney P, Pascale P, Iglesias JF, Eeckhout E, Muller O (2015) Myocardial infarct size and mortality depend on the time of day-a large multicenter study. PLoS One 10:e0119157
Gu JY, Li LW (2014) ALDH2 Glu504Lys polymorphism and susceptibility to coronary artery disease and myocardial infarction in east Asians: a meta-analysis. Arch Med Res 45(1):76–83
Han H, Wang H, Yin Z, Jiang H, Fang M, Han J (2013) Association of genetic polymorphisms in ADH and ALDH2 with risk of coronary artery disease and myocardial infarction: a meta-analysis. Gene 526:134–141
Hausenloy DJ, Yellon DM (2013) Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 123:92–100
He L, Liu B, Dai Z, Zhang HF, Zhang YS, Luo XJ, Ma QL, Peng J (2012) Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation. Eur J Pharmacol 678(1–3):32–38
Heusch G (2015) Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res 116:674–699
Heusch G, Rassaf T (2016) Time to give up on Cardioprotection? A critical appraisal of clinical studies on ischemic pre-, post-, and remote conditioning. Circ Res 119:676–695
Hill GG, Bhatnagar A (2009) Beyond reactive oxygen species: aldehydes as arbitrators of alarm and adaption. Circ Res 105:1044–1046
Hung MJ, Hu P, Hung MY (2014) Coronary artery spasm: review and update. Int J Med Sci 11(11):1161–1171
Ito T, Yasue H, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E, Mizuno Y, Kawano H, Ogawa H (2002) Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm. Hum Genet 110:89–94
JCS Joint Working Group (2014) Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina). Circ J 78:2779–2801
Ji W, Wei S, Hao P, Xing J, Yuan Q, Wang J, Xu F, Chen Y (2016) Aldehyde dehydrogenase 2 has Cardioprotective effects on myocardial/Ischaemia/reperfusion injury via suppressing Mitophagy. Front Pharmacol 7:101
Jo SA, Kim EK, Park MH, Han C, Park HY, Jang Y, Song BJ, Jo I (2007) A Glu487Lys polymorphism in the gene for mitochondrial aldehyde dehydrogenase 2 is associated with myocardial infarction in elderly Korean men. Clin Chim Acta 382:43–47
Katoh D, Mizuno Y, Harada E, Ito T, Morikawa Y, Nakagawa H, Saito Y, Yoshimura M, Yasue H (2012) High incidence of provoked coronary spasm in the presence of a stent after myocardial infarction: therapeutic and prognostic implications. Coron Artery Dis 23:141–145
Kim HO, Kim JM, Woo JS, Park CB, Cho JM, Lee SU, Kim CJ, Jeong MH, Kim W (2018) Korea acute myocardial infarction registry investigators. Circadian distribution of acute myocardial infarction in different age groups. Am J Cardiol 121:1279–1284
Kinlay S (2014) Coronary artery spasm as a cause of angina. Circulation 129:1717–1719
Kosugi M, Nakagomi A, Shibui T, Kato K, Kusama Y, Atarashi H, Mizuno K (2011) Effect of long-term nitrate treatment on cardiac events in patients with vasospastic angina. Circ J 75(9):2196–2205
Kugiyama K, Yasue H, Ohgushi M, Motoyama T, Kawano H, Inobe Y, Hiroshima O, Sugiyama S (1996a) Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol 28:1161–1167
Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, Yoshimura M, Motoyama T, Inobe Y, Kawano H (1996b) Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 94:266–271
Lang XE, Wang X, Zhang KR, Lv JY, Jin JH, Li QS (2013) Isoflurane preconditioning confers cardioprotection by activation of ALDH2. PLoS One 8:e52469
Lemoine S, Tritapepe L, Hanouz JL, Puddu PE (2016) The mechanisms of cardio-protective effects of desflurane and sevoflurane at the time of reperfusion: anaesthetic post-conditioning potentially translatable to humans? Br J Anaesth 116:456–475
Lewis SJ (2010) Mendelian randomization as applied to coronary heart disease, including recent advances incorporating new technology. Circ Cardiovasc Genet 3:109–117
Li Y, Zhang D, Jin W, Shao C, Yan P, Xu C, Sheng H, Liu Y, Yu J, Xie Y, Zhao Y, Lu D, Nebert DW, Harrison DC, Huang W, Jin L (2006) Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. J Clin Invest 116:506–511
Li H, Borinskaya S, Yoshimura K, Kal’ina N, Marusin A, Stepanov VA, Qin Z, Khaliq S, Lee MY, Yang Y, Mohyuddin A, Gurwitz D, Mehdi SQ, Rogaev E, Jin L, Yankovsky NK, Kidd JR, Kidd KK (2009) Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant. Ann Hum Genet 73:335–345
Li RJ, Ji WQ, Pang JJ, Wang JL, Chen YG, Zhang Y (2013) Alpha-lipoic acid ameliorates oxidative stress by increasing aldehyde dehydrogenase-2 activity in patients with acute coronary syndrome. Tohoku J Exp Med 229(1):45–51
Li YY, Wang H, Wu JJ, Kim HJ, Yang XX, Geng HY, Gong G (2018) ALDH2 gene G487A polymorphism and coronary artery disease: a meta-analysis including 5644 participants. J Cell Mol Med 22(3):1666–1674
Libby P (2013) Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 368:2004–2013
Ma H, Guo R, Yu L, Zhang Y, Ren J (2011) Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde. Eur Heart J 32:1025–1038
Mackenzie IS, Maki-Petaja KM, McEniery CM, Bao YP, Wallace SM, Cheriyan J, Monteith S, Brown MJ, Wilkinson IB (2005) Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humans. Arterioscler Thromb Vasc Biol 25(9):1891–1895
Mali VR, Palaniyandi SS (2014) Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease. Free Radic Res 48:251–263
Maseri A, Davies G, Hackett D, Kaski JC (1990) Coronary artery spasm and vasoconstriction. The case for a distinction. Circulation 81:1983–1991
Messner B, Bernhard D (2014) Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol 34:509–515
Miyamoto S, Kawano H, Sakamoto T, Soejima H, Kajiwara I, Hokamaki J, Hirai N, Sugiyama S, Yoshimura M, Yasue H, Nakamura H, Yodoi J, Ogawa H (2004) Increased plasma levels of thioredoxin in patients with coronary spastic angina. Antioxid Redox Signal 6:75–80
Mizuno Y, Harada E, Morita S, Kinoshita K, Hayashida M, Shono M, Morikawa Y, Murohara T, Nakayama M, Yoshimura M, Yasue H (2015) East Asian variant of aldehyde dehydrogenase 2 is associated with coronary spastic angina: possible roles of reactive aldehydes and implications of alcohol flushing syndrome. Circulation 131:1665–1673
Mizuno Y, Hokimoto S, Harada E, Kinoshita K, Nakagawa K, Yoshimura M, Ogawa H, Yasue H (2016a) Variant aldehyde dehydrogenase 2 (ALDH2*2) is a risk factor for coronary spasm and ST-segment elevation myocardial infarction. J Am Heart Assoc 5:pii: e003247
Mizuno Y, Hokimoto S, Harada E, Kinoshita K, Yoshimura M, Yasue H (2016b) Variant aldehyde dehydrogenase 2 (ALDH2*2) in east Asians interactively exacerbates tobacco smoking risk for coronary spasm - possible role of reactive aldehydes. Circ J 81:96–102
Morikawa Y, Mizuno Y, Harada E, Kuboyama O, Yoshimura M, Yasue H (2010) Nitrate tolerance as a possible cause of multidrug-resistant coronary artery spasm. Int Heart J 51:211–213
Morita K, Miyazaki H, Saruwatari J, Oniki K, Kumagae N, Tanaka T, Kajiwara A, Otake K, Ogata Y, Arima Y, Hokimoto S, Ogawa H, Nakagawa K (2014a) Combined effects of current-smoking and the aldehyde dehydrogenase 2*2 allele on the risk of myocardial infarction in Japanese patients. Toxicol Lett 232:221–225
Morita S, Mizuno Y, Harada E, Nakagawa H, Morikawa Y, Saito Y, Katoh D, Kashiwagi Y, Yoshimura M, Murohara T, Yasue H (2014b) Differences and interactions between risk factors for coronary spasm and atherosclerosis--smoking, aging, inflammation, and blood pressure. Intern Med 53:2663–2670
Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, Moriyama Y, Miyao Y, Yoshimura M, Ogawa H, Yasue H (1998) Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 32:1672–1679
Murase Y, Yamada Y, Hirashiki A, Ichihara S, Kanda H, Watarai M, Takatsu F, Murohara T, Yokota M (2004) Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women. Eur Heart J 25:970–977
Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H (1994) Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Phys 266:H874–H880
Nakano T, Osanai T, Tomita H, Sekimata M, Homma Y, Okumura K (2002) Enhanced activity of variant phospholipase C-delta1 protein (R257H) detected in patients with coronary artery spasm. Circulation 105:2024–2029
Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K (1999) T-786-C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864–2870
OECD (2013) Mortality following acute myocardial infarction (AMI). In health at a glance 2013. OECD Indicators, OECD Publishing, Paris, pp 112–113
Opelt M, Eroglu E, Waldeck-Weiermair M, Russwurm M, Koesling D, Malli R, Graier WF, Fassett JT, Schrammel A, Mayer B (2016) Formation of nitric oxide by aldehyde Dehydrogenase-2 is necessary and sufficient for vascular bioactivation of nitroglycerin. J Biol Chem 291:24076–24084
Oshima S, Yasue H, Ogawa H, Okumura K, Matsuyama K (1990) Fibrinopeptide a is released into the coronary circulation after coronary spasm. Circulation 82:2222–2225
Pan C, Zhao Y, Bian Y, Shang R, Wang JL, Xue L, Wei SJ, Zhang H, Chen YG, Xu F (2018) Aldehyde dehydrogenase 2 Glu504Lys variant predicts a worse prognosis of acute coronary syndrome patients. J Cell Mol Med 22(4):2518–2522
Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, Cianflone D, Sanna T, Sasayama S, Maseri A (2000) Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 101:1102–1108
Qian F, Ling FS, Deedwania P, Hernandez AF, Fonarow GC, Cannon CP, Peterson ED, Peacock WF, Kaltenbach LA, Laskey WK, Schwamm LH, Bhatt DL, Get With The Guidelines Steering Committee and Investigators (2012) Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association get with the guidelines-coronary artery disease program. Circ Cardiovasc Qual Outcomes 5:126–133
Reilly M, Delanty N, Lawson JA, FitzGerald GA (1996) Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94:19–25
Schuckit MA (2011) Ethanol and methanol. In: Brnton L, Chabner B, Knollmann BC (eds) Goodman & Gilman’s pharmacological basis of therapeutics, 12th edn. McGraw Hill, New York
Seki T, Okayama H, Isoyama S, Kagaya Y, Shirato K, Munakata K, Kanazawa M, Tamaki K, Hiramoto T, Okayama M, Kasahara S (1999) The role of alcohol dehydrogenase 2 and aldehyde dehydrogenase 2 genotypes in alcohol-induced vasospastic angina. Tohoku J Exp Med 187:311–322
Singh S, Brocker C, Koppaka V, Chen Y, Jackson BC, Matsumoto A, Thompson DC, Vasiliou V (2013) Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress. Free Radic Biol Med 56:89–101
Sohn SM, Choi BG, Choi SY, Byun JK, Mashaly A, Park Y, Jang WY, Kim W, Choi JY, Park EJ, Na JO, Choi CU, Lim HE, Kim EJ, Park CG, Seo HS, Oh DJ, Rha SW (2018) Impact of alcohol drinking on acetylcholine-induced coronary artery spasm in Korean populations. Atherosclerosis 268:163–169
Sun A, Zou Y, Wang P, Xu D, Gong H, Wang S, Qin Y, Zhang P, Chen Y, Harada M, Isse T, Kawamoto T, Fan H, Yang P, Akazawa H, Nagai T, Takano H, Ping P, Komuro I, Ge J (2014) Mitochondrial aldehyde dehydrogenase 2 plays protective roles in heart failure after myocardial infarction via suppression of the cytosolic JNK/p53 pathway in mice. J Am Heart Assoc 3:e000779
Takagi S, Iwai N, Yamauchi R, Kojima S, Yasuno S, Baba T, Terashima M, Tsutsumi Y, Suzuki S, Morii I, Hanai S, Ono K, Baba S, Tomoike H, Kawamura A, Miyazaki S, Nonogi H, Goto Y (2002) Aldehyde dehydrogenase 2 gene is a risk factor for myocardial infarction in Japanese men. Hypertens Res 25:677–681
Takahashi J, Nihei T, Takagi Y, Miyata S, Odaka Y, Tsunoda R, Seki A, Sumiyoshi T, Matsui M, Goto T, Tanabe Y, Sueda S, Momomura S, Yasuda S, Ogawa H, Shimokawa H, Japanese Coronary Spasm Association (2015) Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association. Eur Heart J 36:228–237
Takeuchi F, Yokota M, Yamamoto K, Nakashima E, Katsuya T, Asano H, Isono M, Nabika T, Sugiyama T, Fujioka A, Awata N, Ohnaka K, Nakatochi M, Kitajima H, Rakugi H, Nakamura J, Ohkubo T, Imai Y, Shimamoto K, Yamori Y, Yamaguchi S, Kobayashi S, Takayanagi R, Ogihara T, Kato N (2012) Genome-wide association study of coronary artery disease in the Japanese. Eur J Hum Genet 20:333–340
Takizawa A, Yasue H, Omote S, Nagao M, Hyon H, Nishida S, Horie M (1984) Variant angina induced by alcohol ingestion. Am Heart J 107:25–27
Wakabayashi K, Suzuki H, Honda Y, Wakatsuki D, Kawachi K, Ota K, Koba S, Shimizu N, Asano F, Sato T, Takeyama Y (2008) Provoked coronary spasm predicts adverse outcome in patients with acute myocardial infarction. a novel predictor of prognosis after acute myocardial infarction J Am Coll Cardiol 52:518–522
World Health Organization (2008) WHO Report on the global tobacco epidemic. 2008; 67176. http://www.who.int/tobacco/global_report/summary/en/#. Accessed 16 Feb 2016
Xu F, Chen YG, Xue L, Li RJ, Zhang H, Bian Y, Zhang C, Lv RJ, Feng JB, Zhang Y (2011) Role of aldehyde dehydrogenase 2 Glu504lys polymorphism in acute coronary syndrome. J Cell Mol Med 15:1955–1962
Xu F, Sun Y, Shang R, Li M, Cui L, Cui Z, Chen Y (2014) The Glu504Lys polymorphism of aldehyde dehydrogenase 2 contributes to development of coronary artery disease. Tohoku J Exp Med 234:143–150
Yasue H, Sasayama S, Kikuchi K, Okumura K, Matsubara T, Miwa K, Gotoh Y, Shimokawa H, Yokoyama M, Yokoyama H, Nakamura Y, Kawada M, Inoue K, Nakamura K (2000) The study on the role of CAS in ischemic heart disease. In: Annual report of the research on cardiovascular diseases 2000. National Cardiovascular Center, Osaka, pp 96–97. (in Japanese)
Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y (2008) Coronary artery spasm—clinical features, diagnosis, pathogenesis, and treatment. J Cardiol 51:2–17
Yokoyama A, Omori T, Yokoyama T (2010) Alcohol and aldehyde dehydrogenase polymorphisms and a new strategy for prevention and screening for cancer in the upper aerodigestive tract in East Asians. Keio J Med 59:115–130
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yasue, H., Mizuno, Y., Harada, E. (2019). Association of East Asian Variant Aldehyde Dehydrogenase 2 Genotype (ALDH2*2*) with Coronary Spasm and Acute Myocardial Infarction. In: Ren, J., Zhang, Y., Ge, J. (eds) Aldehyde Dehydrogenases. Advances in Experimental Medicine and Biology, vol 1193. Springer, Singapore. https://doi.org/10.1007/978-981-13-6260-6_7
Download citation
DOI: https://doi.org/10.1007/978-981-13-6260-6_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-6259-0
Online ISBN: 978-981-13-6260-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)